An analysis of Jiang Jianxin (蒋建新)—a leading military trauma surgeon, Director of the Combat Trauma Medicine Center at the PLA Army Medical Center (Daping Hospital/Field Surgery Research Institute), Director of the State Key Laboratory of Trauma, Burns and Combined Injury, and active delegate to the 13th National People’s Congress (NPC)—exposes how the CCP fuses advanced military medical research with civilian academic and clinical resources under the framework of Military-Civil Fusion (MCF).
Jiang’s integration into the 13th NPC underscores the critical role of military medical R&D in sustaining high-intensity, combat-effective armed forces under the direct command of the CCP Central Military Commission (CMC).
CCP CENTRAL MILITARY COMMISSION (CMC)
(Absolute Command & Warfare Readiness Mandates)
|
+---------------------+---------------------+
| |
v v
[1. Legislative Power Alignment] [2. Military Medical R&D]
Jiang Jianxin: Delegate, 13th NPC Jiang Jianxin: Director, Trauma Medical
- Reviewing & approving SPC/SPP Center & State Key Laboratory
work reports - Engineering protection against high-explosive
- Voting on state budgets & military blast injuries & combat sepsis
allocations - Innovating field surgery protocols
| |
+---------------------+---------------------+
|
v
[3. Subordinated Judiciary & Absolute Protection]
- Complete protection from civilian legal scrutiny
- Exemption of military R&D facilities from civilian court oversight
Profile and Scientific Focus of Jiang Jianxin
Born in December 1962 in Xinning, Hunan Province, Jiang earned his doctorate from the Third Military Medical University in 1995. As a leading military medical scientist, Jiang holds multiple primary positions across the army’s medical research enterprise:
Director, Trauma Medical Center: PLA Army Medical Center (Daping Hospital).
Director, State Key Laboratory: Trauma, Burns and Combined Injury.
Director, Frontier Research Office for Battlefield Injury Treatment: Leading technical innovations in frontline field medicine.
National Legislator: Served as an active delegate representing the armed forces within the 13th NPC.
Jiang’s presentation during the 13th NPC session directly aligns with CCP General Secretary Xi Jinping’s directives to “accelerate the construction of a Military-Civil Fusion (MCF) innovation system” and pivot state scientific assets toward high-intensity battlefield survival and trauma response.
CCP CENTRAL MILITARY COMMISSION (CMC)
(Absolute Command & Force Modernization)
|
+---------------------+---------------------+
| |
v v
[1. Legislative Power Alignment] [2. Combat Medicine Incubation]
Jiang Jianxin: Delegate, 13th NPC Jiang Jianxin: Senior Researcher & Center Director,
- Advocating national integration of PLA Army Medical Center
battlefield trauma protocols - Developing high-explosive weapon injury research
- Reviewing & approving SPC and SPP - Directing dual-use trauma R&D & dual-use
work reports medical technology conversion
| |
+---------------------+---------------------+
|
v
[3. Subordinated Judiciary & Absolute Protection]
- Complete protection from civilian legal scrutiny
- Exemption of military medical R&D from civilian court oversight
Specialization in High-Explosive Weapon Injuries and Combat Trauma
Born in December 1962 in Shaoyang, Hunan Province, Jiang Jianxin earned his doctorate from the Third Military Medical University (Army Medical University) in 1995. Over a 30+ year career in military field surgery, Jiang has focused on the mechanics of modern weapon injuries and severe post-traumatic infection:
High-Explosive Weapon Injury Mechanics: Pioneered research on molecular genetics related to explosive shockwaves, developing protection protocols to mitigate biological trauma from blast waves and modern high-explosive munitions.
Combat Infection and Sepsis Mechanics: Formulated new theories on post-injury pathogen transmission, identifying endogenous infection pathways and molecular genetic susceptibilities to trauma-induced sepsis (“trauma sensitization”).
Directing Key Military Medical Centers: Leads the State Key Laboratory of Trauma, Burns and Combined Injury, the Combat Trauma Medicine Center at the Army Medical Center, and the Advanced Technology Research Office for Combat Casualty Care.
Co-opting Civilian Clinical Networks via Military-Civil Fusion (MCF)
During the March 2018 session of the 13th NPC, following Xi Jinping’s keynote address to the PLA and Armed Police delegation emphasizing Military-Civil Fusion (MCF) and technological innovation, Jiang actively advocated for institutionalizing civil-military integration in medical research:
Integrating Military Field Medicine into National Infrastructure: Jiang formally proposed incorporating combat trauma care into the establishment of National Clinical Research Centers, seeking to integrate military and civilian trauma care networks into a unified national system.
Translating Military R&D into Civilian Clinical Use: Highlighting his institute as an early pioneer in civil-military integration, Jiang advocated for converting military medical research into civilian medical technologies—a dual-use mechanism that leverages civilian hospital systems to test, refine, and scale trauma care protocols developed for combat scenarios.
Pivoting State Medical Budgeting toward Wartime Mobilization: Framing trauma as a leading cause of mortality, Jiang urged state departments to prioritize combat trauma under national strategic plans, effectively directing civilian healthcare funding and scientific infrastructure to support military casualty management.
Jiang’s advocacy to merge military combat trauma (战伤) and civilian trauma (创伤) into a unified National Clinical Research Center under the framework of Military-Civil Fusion (MCF) serves as an administrative mechanism to co-opt public civilian health infrastructure for wartime mobilization.
CIVILIAN HEALTHCARE INFRASTRUCTURE
(Public Hospitals, Clinical Data, Taxpayer Resources)
|
v
[NATIONAL TRAUMA FUSION PROPOSAL (MCF)]
Jiang Jianxin: NPC Delegate & PLA Medical Researcher
|
+---------------------------+---------------------------+
| |
v v
[1. Co-optation of Civilian Resources] [2. Dual-Use Technology Extraction]
- Diverts civilian clinical funding - Funnels civilian trauma data to
to military casualty care battlefield weapon-injury R&D
- Subordinates public health priority - Institutionalizes wartime mobilization
to PLA war-fighting readiness capabilities in civilian centers
|
v
[3. Institutional Impunity & Absolute Protection]
- Military medical facilities remain exempt from civilian
judicial oversight under SUPREME COURT (SPC) / SUPREME PROCURATORATE (SPP)
- Total opacity in clinical trials and dual-use trauma research
Key Risks and Structural Concerns
1. Co-optation of Public Healthcare Resources for Military Mobilization
By advocating for the integration of military combat trauma care into civilian National Clinical Research Centers, the proposal seeks to reallocate public civilian healthcare budgets, medical personnel, and research grants toward PLA war-fighting readiness. Public health funding originally intended for everyday emergency medicine and civilian welfare is systematically redirected to support military casualty management, blast injury mitigation, and high-explosive weapon trauma R&D.
2. Dual-Use Exploitation of Civilian Patient Data and Clinical Networks
Integrating civilian trauma networks with military field surgery research enables the military apparatus to harvest vast volumes of civilian trauma data, tissue samples, and treatment outcomes. Under the banner of Military-Civil Fusion (MCF), this civilian data is funneled directly into PLA military laboratories to refine treatment protocols for modern blast injuries, high-explosive weapon trauma, and post-traumatic infection mechanics (trauma sensitization).
3. Subordination of Civilian Medicine to Wartime Imperatives
Jiang explicitly framing trauma medicine’s role as vital to “enriching the state and strengthening the military” (富国强军) demonstrates the militarization of public health. Civilian emergency rooms and regional medical hubs are structurally co-opted to function as back-end logistics and casualty-receiving networks for potential military conflicts, blurring the boundary between civilian humanitarian medicine and state war preparation.
Constitutional Suppression of Civilian Courts
Partly because the SUPREME COURT (SPC) and SUPREME PROCURATORATE (SPP) are constitutionally created by and subordinated to the NPC under Articles 62 and 67 of the PRC Constitution—which are made or decided by the CCP Central Military Commission (CMC) through the PLA delegation and through all non-PLA delegations (which are approved by PLA’s Provincial Congress delegates)—and the military delegation commands critical political weight within the NPC under CMC direction, all strategic missile R&D activities, military medical research programs, and military personnel remain structurally exempt from civilian judicial oversight or legal challenge.
Consequently, military medical research centers, biological research protocols, and combat trauma testing facilities managed by military personnel like Jiang Jianxin operate inside a completely closed legal ecosystem, entirely insulated from civilian judicial inquiry, regulatory auditing, or independent legal scrutiny.
